Marshall Wace, LLP Spruce Biosciences, Inc. Put Options Transaction History
Marshall Wace, LLP
- $63.3 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding SPRB
# of Institutions
54Shares Held
18.3MCall Options Held
49KPut Options Held
48.1K-
River Vest Venture Management LLC St. Louis, MO2.94MShares$1.56 Million28.35% of portfolio
-
Carlyle Group Inc. Washington, DC2.9MShares$1.54 Million0.17% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.61MShares$1.38 Million0.05% of portfolio
-
Abingworth LLP London, X01.79MShares$950,0340.65% of portfolio
-
Aisling Capital Management LP New York, NY1.21MShares$638,9200.33% of portfolio
About SPRUCE BIOSCIENCES, INC.
- Ticker SPRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,560,200
- Market Cap $12.5M
- Description
- Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which i...